| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |